Litcius/Paper detail

Targeting PI3K/AKT/mTOR pathway to enhance the anti-leukemia efficacy of venetoclax

Hongcai Liu, Zubair Hussain, Qingqing Xie, Xueying Yan, Chenxing Zeng, Gan Zhou, Shan Cao

2022Experimental Cell Research18 citationsDOI

Topics & Concepts

PI3K/AKT/mTOR pathwayMyeloid leukemiaVenetoclaxBiologyProtein kinase BApoptosisCancer researchFlow cytometryIn vivoLeukemiaPharmacologyWestern blotDownregulation and upregulationMyeloidImmunologyBiochemistryBiotechnologyChronic lymphocytic leukemiaGeneAcute Myeloid Leukemia ResearchPI3K/AKT/mTOR signaling in cancerMicrotubule and mitosis dynamics
Targeting PI3K/AKT/mTOR pathway to enhance the anti-leukemia efficacy of venetoclax | Litcius